Psychometric Testing of the Decisional Conflict Scale: Genetic Testing Hereditary Breast and Ovarian Cancer
Katapodi, Maria C
Munro, Michelle L
Pierce, Penny F
Williams, Reg A
Nursing research 2011 Nov-Dec; 60(6): 368-77
: Hereditary breast and ovarian cancer (HBOC) syndrome is attributed mostly to mutations in the Breast Cancer 1 and Breast Cancer 2 genes (BRCA1/2). Mutation carriers of BRCA1/2 genes have significantly higher risk for developing breast cancer compared with the general population (55%-85% vs. 12%) and for developing ovarian cancer (20%-60% vs. 1.5%). The availability of genetic testing enables mutation carriers to make informed decisions about managing their cancer risk (e.g., risk-reducing surgery). However, uptake of testing for HBOC among high-risk individuals is low, indicating the need to better understand and measure the decisional conflict associated with this process.
Showing items related by title, author, creator and subject.
Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation Claes, Erna; Evers-Kiebooms, Gerry; Boogaerts, Andrea; Decruyenaere, Marleen; Denayer, Lieve; Legius, Eric (2004-03)
De Vos, M.; Poppe, B.; Delvaux, I.; Mortier, G.; Claes, K.; Messiaen, L.; De Paepe, A. (1999-10)
Comparing family members' motivations and attitudes towards genetic testing for hereditary breast and ovarian cancer: a qualitative analysis. Dancyger, Caroline; Smith, Jonathan A; Jacobs, Chris; Wallace, Melissa; Michie, Susan (2010-12)Genetic testing for hereditary breast and ovarian cancer reveals significant risk information regarding one's chances of developing cancer that has potential implications for patients and their families. This study reports ...